These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4231881)

  • 21. Role of the autonomic nervous system in the resting tachycardia of experimental hyperthyroidism.
    Cairoli VJ; Crout JR
    J Pharmacol Exp Ther; 1967 Oct; 158(1):55-65. PubMed ID: 6054081
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experiments of the viloxazine-noradrenaline interaction on the atrium and the isolated ductus defens of the rat. Comparison with imipramine].
    García Morillas M; Puche E; Mundo A; Arias A
    Arch Farmacol Toxicol; 1980 Apr; 6(1):83-8. PubMed ID: 7387207
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cardiac dynamics in states of excitation, in dogs: changes after blocking of beta adrenergic receptors].
    Granata L; Pasquè A; Pinotti O
    Boll Soc Ital Biol Sper; 1967 Apr; 43(7):362-6. PubMed ID: 6052522
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitative changes in beta-adrenergic responses of isolated atria from hyper- and hypothyroid rats.
    Rub HP; Thommen H; Porzig H
    Experientia; 1981 Apr; 37(4):399-401. PubMed ID: 6263681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A receptor kinetic model of a vascular neuroeffector.
    Johansson B; Johansson SR; Ljung B; Stage L
    J Pharmacol Exp Ther; 1972 Mar; 180(3):636-46. PubMed ID: 4401158
    [No Abstract]   [Full Text] [Related]  

  • 26. Antagonism by propranolol of the cardiac chronotropic response to norepinephrine or to transmural electrical stimulation.
    Thompson EB; West TC
    J Pharmacol Exp Ther; 1968 Jun; 161(2):232-7. PubMed ID: 5650136
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
    Levy JV
    J Clin Pharmacol New Drugs; 1971; 11(4):249-60. PubMed ID: 4397374
    [No Abstract]   [Full Text] [Related]  

  • 28. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 29. The influence of hyperthyroidism and hypothyroidism on alpha- and beta-adrenergic receptor systems and adrenergic responsiveness.
    Bilezikian JP; Loeb JN
    Endocr Rev; 1983; 4(4):378-88. PubMed ID: 6317368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fate of 3 H-norepinephrine released from isolated atria and vas deferens: effect of field stimulation.
    Tarlov SR; Langer SZ
    J Pharmacol Exp Ther; 1971 Nov; 179(2):186-97. PubMed ID: 4399959
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison of the adrenergic receptor blocking properties of 1-(4'-methylphenyl)-2-isopropylamino-propanol-HCl and propranolol.
    Levy B
    J Pharmacol Exp Ther; 1967 Jun; 156(3):452-62. PubMed ID: 6067476
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of adrenergic agonists on tension development and rate in atria from euthyroid and hypothyroid rats.
    Simpson WW; McNeill JH
    Adv Myocardiol; 1980; 1():417-35. PubMed ID: 6104853
    [No Abstract]   [Full Text] [Related]  

  • 33. Beta2-adrenoceptor-mediated prejunctional facilitation and postjunctional inhibition of sympathetic neuroeffector transmission in the guinea pig vas deferens.
    Todorov LD; Clerkin R; Mihaylova-Todorova ST; Khoyi MA; Westfall DP
    J Pharmacol Exp Ther; 2001 Aug; 298(2):623-33. PubMed ID: 11454924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.
    Brittsan AG; Kiss E; Edes I; Grupp IL; Grupp G; Kranias EG
    J Mol Cell Cardiol; 1999 Sep; 31(9):1725-37. PubMed ID: 10471356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnesium and reserpine influence norepinephrine sensitivity of vas deferens in rats.
    Gandhi DN; Venkatakrishna-Bhatt H
    Indian J Physiol Pharmacol; 1993 Apr; 37(2):109-14. PubMed ID: 8225541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual adrenergic blockade and epinephrine infusion.
    Nash CB
    J Pharmacol Exp Ther; 1968 Aug; 162(2):246-53. PubMed ID: 5674105
    [No Abstract]   [Full Text] [Related]  

  • 37. Altered muscle sympathetic nerve activity in hyperthyroidism and hypothyroidism.
    Matsukawa T; Mano T; Gotoh E; Minamisawa K; Ishii M
    J Auton Nerv Syst; 1993 Feb; 42(2):171-5. PubMed ID: 8450175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on thyroid-catecholamine interactions in the isolated rabbit heart.
    Anton AH; Gravenstein JS
    Eur J Pharmacol; 1970; 10(3):311-8. PubMed ID: 5422456
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship between aortic reactivity and blood pressure of renal hypertensive, hyperthyroid, and hypothyroid rats.
    Field FP; Janis RA; Triggle DJ
    Can J Physiol Pharmacol; 1973 May; 51(5):344-53. PubMed ID: 4746702
    [No Abstract]   [Full Text] [Related]  

  • 40. Baroreflex-governed sympathetic outflow to muscle vasculature is increased in hypothyroidism.
    Fagius J; Westermark K; Karlsson A
    Clin Endocrinol (Oxf); 1990 Aug; 33(2):177-85. PubMed ID: 2225477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.